On July 8, 2026, Shanghai Lishan Biotech Co., Ltd. officially received the Intellectual Property Compliance Management System Certification Certificate issued by Zhongzhi (Beijing) Certification Co., Ltd.

This certification marks a further upgrade in the systematic management of the Company’s intellectual property work. It represents a key achievement of Lishan Biotech in continuously improving its innovation management system and strengthening its capability to protect core technologies, laying a more solid foundation for AI‑empowered living biologic drug R&D and future industrial development.

Intellectual property constitutes a vital component of the core competitiveness of innovative enterprises, as well as critical support for translating scientific research achievements into industrial applications. The acquisition of this certification bears witness to Lishan Biotech’s accomplishments in refining its innovation management system and stepping up strategic intellectual property layout.

From Institutional Development to System Certification

As a biopharmaceutical enterprise driven primarily by technological innovation, Lishan Biotech attaches great importance to strategic intellectual property layout. To further enhance intellectual property management capacity and enable efficient transformation of R&D innovations, the Company launched the development of its intellectual property management system, advancing systematic work covering R&D innovation, patent portfolio building, achievement protection and standardized administration.

The system development went through multiple phases including preparation, initiation, implementation, internal audit and formal certification audit.

Leveraging the Intellectual Property System to Underpin Long‑term Innovative Drug Development

The passing of this intellectual property management system certification will further enable the Company to:

• Enhance end‑to‑end intellectual property management capabilities;
• Strengthen protection for core technologies and R&D outputs;
• Boost the translation and application of innovative achievements;
• Underpin the enterprise’s long‑term innovation‑driven growth.

Going forward, Lishan Biotech will continue to optimize its intellectual property strategic layout. Supported by a more standardized and efficient innovation management system, the Company will advance the development of microbiome therapeutics and bring more innovative treatment options to patients.

About Zhongzhi (Beijing) Certification Co., Ltd.

Zhongzhi (Beijing) Certification Co., Ltd. is China’s first third‑party certification body for intellectual property management systems approved by the Certification and Accreditation Administration of China (CNCA) and duly registered with state‑level registration authorities. It was founded by the China Patent Protection Association. As a specialized intellectual property certification institution, Zhongzhi carries out certification services for standardized enterprise intellectual property management. Through audit and assessment, it guides enterprises to establish intellectual property management systems compliant with relevant standards.

About Lishan Biotech

Lishan Biotech is a biopharmaceutical enterprise focused on AI‑empowered living biologic drug research and development, addressing massive unmet clinical needs in inflammatory bowel disease, oncology, neurological disorders and beyond. Adopting an “AI + microbiome” strategy, the Company modulates microbial ecology and intervenes in host pathways to generate synergistic effects, systematically expanding the frontiers of microbiome‑based therapeutics. Its current pipeline centers on three high‑value areas: inflammatory bowel disease, metabolism and oncology, striving to develop innovative therapies with First‑in‑Class or Best‑in‑Class potential. Backed by its proprietary Swarming technological moat and AI‑driven clinical patient enrollment strategy, Lishan Biotech is growing rapidly into a world‑leading innovative platform enterprise in microbiome therapeutics, building an indispensable core enabling hub.